Opportunity Information: Apply for PA 09 130
Apply for PA 09 130
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Exploratory Grants for Behavioral Research in Cancer Control (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213 Research and Training in Complementary and Integrative Health 93.399 Cancer Control.
- This funding opportunity was created on Mar 13, 2009 and posted on Mar 13, 2009.
- Applicants must submit their applications by May 7, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses Small businesses Private institutions of higher education County governments State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Eligible Agencies of the Federal Government Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Exploratory Grants for Behavioral Research in Cancer Control (R21) opportunity (Funding Opportunity Number PA 09-130) was a National Institutes of Health discretionary grant program led by the National Cancer Institute (NCI) in collaboration with the National Center for Complementary and Alternative Medicine (NCCAM). Its central goal was to stimulate early-stage, developmental behavioral research that can strengthen cancer prevention and cancer control efforts across the full cancer control continuum, including survivorship and community-based settings. The program was designed to help investigators generate foundational evidence, refine approaches, and develop tools that can later support larger, more definitive studies.
This FOA emphasized innovative pilot work and feasibility studies from a behavioral perspective. In practical terms, it supported projects that test whether a behavioral intervention is workable, acceptable to participants, and implementable in real-world environments, rather than requiring a full-scale efficacy or effectiveness trial at the outset. It also explicitly welcomed rigorous qualitative or mixed-methods work when those methods are the best fit for understanding context, barriers, facilitators, and user experiences, or for judging whether an intervention shows enough promise to warrant a larger trial. Another major focus was measurement development: applicants were encouraged to propose psychometric evaluation of new instruments or to adapt and validate culturally appropriate measures for populations where suitable tools do not yet exist or have not been validated.
The scientific scope tied together several NCI priority areas and program interests, including the Behavioral Research Program, the Office of Cancer Survivorship, and the Community Oncology and Prevention Trials Research Group. This framing signaled interest in research that connects behavioral science to prevention and screening behaviors, treatment-related decision-making and adherence, survivorship outcomes, and interventions that can work in community oncology and prevention trial networks. The announcement also encouraged small, cross-disciplinary teams, bringing together behavioral and social science expertise with other public health or related disciplines, reflecting the idea that cancer control problems often require integrated perspectives.
Funding was provided under the NIH Exploratory/Developmental R21 mechanism, which is typically used for early, high-potential projects that may be too preliminary for larger grants. The listed award ceiling was $200,000, and the announcement noted that the size and duration of awards could vary depending on the nature and scope of proposed work. The total number of awards and total dollars were not fixed in advance and would depend on the volume and quality of applications received, as well as the requested budgets and project periods.
Eligibility was broad and included many organization types: public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for-profit organizations (including small businesses), and governmental entities such as county and state governments. The FOA also allowed additional applicants such as eligible federal agencies, U.S. territories or possessions, foreign (non-U.S.) entities, and regional organizations. Cost sharing or matching was not required.
Key dates indicate this was a time-limited opportunity that has since closed and been archived. It was posted and created on March 13, 2009, with an original and final closing date of May 7, 2012, and an archive date of June 7, 2012. The program was associated with CFDA numbers 93.213 (Research and Training in Complementary and Integrative Health) and 93.399 (Cancer Control), reflecting the participating NIH components and the cancer control emphasis.
In short, PA 09-130 funded early, exploratory behavioral cancer control research intended to spark innovation, test feasibility, and build measurement and intervention groundwork, especially where culturally appropriate tools and timely pilot data are needed to move the field toward larger, more definitive cancer prevention, control, and survivorship studies.
Frequently Asked Questions (FAQs): Exploratory Grants for Behavioral Research in Cancer Control (R21) - PA 09-130
What is the PA 09-130 funding opportunity?
PA 09-130, titled "Exploratory Grants for Behavioral Research in Cancer Control (R21)," was a National Institutes of Health (NIH) discretionary grant opportunity led by the National Cancer Institute (NCI) in collaboration with the National Center for Complementary and Alternative Medicine (NCCAM).
What was the main purpose of this opportunity?
The central goal was to stimulate early-stage, developmental behavioral research that could strengthen cancer prevention and cancer control across the full cancer control continuum, including survivorship and community-based settings.
What kind of research did this program aim to stimulate?
This program emphasized innovative pilot work and feasibility studies from a behavioral perspective. It was intended to help investigators generate foundational evidence, refine approaches, and develop tools that could later support larger, more definitive studies.
What areas of cancer control were included in the scope?
The scope covered the full cancer control continuum, specifically including cancer prevention, cancer control, survivorship, and community-based settings where cancer control efforts take place.
Was this intended to fund full-scale efficacy or effectiveness trials?
No. The FOA emphasized early exploratory work. It supported studies that evaluate whether a behavioral intervention is workable, acceptable to participants, and implementable in real-world environments, rather than requiring a full-scale efficacy or effectiveness trial at the outset.
What kinds of study designs and methods were welcomed?
The announcement explicitly welcomed rigorous qualitative or mixed-methods research when those approaches were the best fit for understanding context, barriers, facilitators, and user experiences, or for judging whether an intervention showed enough promise to warrant a larger trial.
Did the opportunity support measurement or instrument development?
Yes. Measurement development was a major focus. Applicants were encouraged to propose psychometric evaluation of new instruments and/or adapt and validate culturally appropriate measures for populations where suitable tools did not yet exist or had not been validated.
Which NIH organizations were involved?
The program was led by NCI in collaboration with NCCAM (as named in the opportunity description).
How did the FOA connect to NCI priorities and programs?
The scientific scope tied together several NCI priority areas and program interests, including the Behavioral Research Program, the Office of Cancer Survivorship, and the Community Oncology and Prevention Trials Research Group. This framing signaled interest in behavioral science aligned with prevention and screening behaviors, treatment-related decision-making and adherence, survivorship outcomes, and community oncology and prevention trial network settings.
Did the program encourage collaborative or cross-disciplinary teams?
Yes. The announcement encouraged small, cross-disciplinary teams that bring behavioral and social science expertise together with other public health or related disciplines, reflecting the idea that cancer control challenges often require integrated perspectives.
What grant mechanism was used?
Funding was provided under the NIH Exploratory/Developmental R21 mechanism, which is typically used for early, high-potential projects that may be too preliminary for larger grants.
What was the maximum award amount listed?
The listed award ceiling was $200,000.
Were award size and project duration fixed?
No. The announcement noted that the size and duration of awards could vary depending on the nature and scope of the proposed work.
Were the total number of awards and total dollars predetermined?
No. The total number of awards and total dollars were not fixed in advance and depended on the volume and quality of applications, as well as the requested budgets and project periods.
Who was eligible to apply?
Eligibility was broad and included public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for-profit organizations (including small businesses), and governmental entities such as county and state governments.
Were any additional applicant types allowed?
Yes. The FOA also allowed eligible federal agencies, U.S. territories or possessions, foreign (non-U.S.) entities, and regional organizations.
Was cost sharing or matching required?
No. Cost sharing or matching was not required.
Is this funding opportunity still open?
No. This was a time-limited opportunity that has since closed and been archived.
When was the opportunity posted and when did it close?
It was posted and created on March 13, 2009. The original and final closing date was May 7, 2012.
When was the opportunity archived?
The archive date was June 7, 2012.
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number was PA 09-130.
What CFDA numbers were associated with this program?
The opportunity was associated with CFDA numbers 93.213 (Research and Training in Complementary and Integrative Health) and 93.399 (Cancer Control).
What types of outcomes or deliverables was this program trying to enable?
The program aimed to help investigators build groundwork for larger studies by generating foundational evidence, refining behavioral intervention approaches, developing and testing feasibility and acceptability in real-world settings, and strengthening measurement tools (including culturally appropriate measures where validation was lacking).
Browse more opportunities from the same category: Education Health
Next opportunity: Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21)
Previous opportunity: Supplemental and Alternative Crops Competitive Grants Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 09 130
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 09 130) also looked into and applied for these:
| Funding Opportunity |
|---|
| Interventions to Improve Palliative Care at the End of Life (R01) Apply for RFA NR 09 004 Funding Number: RFA NR 09 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Incorporating Cost Effectiveness Analysis Into Factors Affecting Quality of Life Health Related Research (R01) Apply for RFA NR 09 005 Funding Number: RFA NR 09 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Research on Clinical Decision Making in People with or at Risk for Life Threatening Illness (R21) Apply for PA 09 121 Funding Number: PA 09 121 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Biomedical Research on the International Space Station (BioMed ISS) (UH2/UH3) Apply for PAR 09 120 Funding Number: PAR 09 120 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Building System Capacity for Implementing Evidence Based Practices in Substance Abuse Treatment and Prevention (R34) Apply for PA 09 105 Funding Number: PA 09 105 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Surveillance Using Health Claims based Data System (R03) Apply for PA 09 143 Funding Number: PA 09 143 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Surveillance Using Health Claims based Data System (R21) Apply for PA 09 144 Funding Number: PA 09 144 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Cancer Surveillance Using Health Claims based Data System (R01) Apply for PA 09 145 Funding Number: PA 09 145 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pilot and Feasibility Studies in Preparation for Drug Abuse Prevention Trials (R34) Apply for PA 09 146 Funding Number: PA 09 146 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Economic Studies of Health Insurance Coverage on Drug Abuse Treatment Availability, Access, Costs, and Quality (R01) Apply for RFA DA 10 004 Funding Number: RFA DA 10 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Studies of Energy Balance and Cancer in Humans (R01) Apply for PA 09 148 Funding Number: PA 09 148 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Studies of Energy Balance and Cancer in Humans (R21) Apply for PA 09 149 Funding Number: PA 09 149 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (P01) Apply for PAR 09 147 Funding Number: PAR 09 147 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| In vivo Cellular and Molecular Imaging Centers (ICMICs) (P50) Apply for PAR 09 157 Funding Number: PAR 09 157 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,250,000 |
| NLM Applied Informatics Grants (G08) Apply for RFA LM 09 001 Funding Number: RFA LM 09 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Developmental Research in Cancer Prognosis and Prediction (R21) Apply for PA 09 158 Funding Number: PA 09 158 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Developmental Research in Cancer Prognosis and Prediction (R33) Apply for PA 09 159 Funding Number: PA 09 159 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) Apply for PAR 09 160 Funding Number: PAR 09 160 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Basic Cancer Research in Cancer Health Disparities (U01) Apply for PAR 09 161 Funding Number: PAR 09 161 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Developmental Projects in Complementary Approaches to Cancer Care and Treatment (R21) Apply for PA 09 167 Funding Number: PA 09 167 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 09 130", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.